If you missed the "Extending Life and Limb" workshop on regenerative medicine held last week at the OneMedForum conference in San Francisco, you can watch the full panel discussion on YouTube at the link below.
Crystal Research Associates' co-founder and CEO, Jeffrey Kraws, was among leading stock analysts and experts discussing the most important developments in the stem cell and regenerative medicine space and opportunities for investors. Regenerative medicine continues to impact and create new innovations and opportunities for investors. As they get to the cellular level, breakthroughs are on the horizon to manage an aging population. View this panel discussion to learn about the key drivers and areas of growth for investors.
Speakers also included Dr. Stephen Chang, vice president for research and development at the New York Stem Cell Foundation, and Jason Kolbert, managing director, biotechnology at the Maxim Group LLC.
